pembrolizumab
merck
['melanoma', 'pembro']
patients with high-risk #melanoma who received pembrolizumab both before &amp; after surgery to remove cancerous tissue had a significantly lower risk of their cancer recurring than similar patients who received the drug only after surgery. #esmo22 #immunotherapy 
The company is a leading provider of an AI-powered precision oncology platform transforming biomarker discovery and treatment decisions.